EFFECTS OF CISPLATIN AND PHENYLETHYL ISOTHIOCYANATE ON HEAD AND NECK CANCER CELLS

Bibliographic Information

Other Title
  • 頭頚部癌細胞におけるイソチオシアネート併用によるCDDP効果増強の試み  (第二報)

Search this article

Abstract

Development of resistance to cisplatin is a major obstacle to successful treatment. Studies were conducted to investigate overcoming resistance to cisplatin. Simultaneous administration of cisplatin and 2-(4-hydroxyphenyl) ethyl isothiocyanate (hITC) to cancer cells increased cell killing and apoptosis induced through a p53-dependent or-independent pathway. And, activation of SAPK/JNK (stress-activated protein kinase/c-Jun N-terminal kinase) was involved in the apoptosis induced by cisplatin and hITC. Taken together with previous findings that p53 mutations are involved in 65% of oral and oropharyngeal cancers, and that cisplatin kills cancer cells mainly by apoptotic induction, it is suggested that hITC may be a useful agent for treatment of cisplatin-resistant cancers or cancers with p53 mutation.

Journal

References(11)*help

See more

Details 詳細情報について

Report a problem

Back to top